TADA2L anticorps (C-Term)
Aperçu rapide pour TADA2L anticorps (C-Term) (ABIN927443)
Antigène
Voir toutes TADA2L (TADA2A) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Purified
-
Immunogène
- TADA2 L antibody was raised in rabbit using the C terminal of TADA2 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
TADA2L Blocking Peptide, (ABIN5616495), is also available for use as a blocking control in assays to test for specificity of this TADA2L antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- TADA2L (TADA2A) (Transcriptional Adaptor 2A (TADA2A))
-
Autre désignation
- TADA2L
-
Sujet
- Many DNA-binding transcriptional activator proteins enhance the initiation rate of RNA polymerase II-mediated gene transcription by interacting functionally with the general transcription machinery bound at the basal promoter. Adaptor proteins are usually required for this activation, possibly to acetylate and destabilize nucleosomes, thereby relieving chromatin constraints at the promoter. TADA2L is a transcriptional activator adaptor and has been found to be part of the PCAF histone acetylase complex. Synonyms: Polyclonal TADA2L antibody, Anti-TADA2L antibody, transcriptional adaptor 2A antibody, ADA2 antibody, ADA2A antibody, FLJ12705 antibody, KL04P antibody, TADA2L antibody, hADA2 antibody.
-
Pathways
- Chromatin Binding
Antigène
-